Search - tctmd.com

Displaying 401 - 420 of 2240

Sort: Relevancy | Date

News Daily News

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Todd Neale

March 06, 2016

Presentation

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

Presenter: Pil Hyung Lee

March 03, 2016

News Daily News

推迟任意类型的支架患者的非心脏手术至少一年：登记表分析

L.A. McKeown

March 01, 2016

News Daily News

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

L.A. McKeown

March 01, 2016

News Daily News

Análisis de Registro: Postponer Cirugías No Cardíacas al Menos 1 Año en Pacientes Con Cualquier Tipo de Stents

L.A. McKeown

March 01, 2016

Presentation

Cardiovascular Risk of Prior Stent Implantation Among Patients Undergoing Noncardiac Surgery

Presenter: Karim D. Mahmoud

February 29, 2016

News Industry News

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

February 28, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Daily News

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Michael O'Riordan

February 23, 2016

News Industry News

REVA Achieves Target Patient Enrollment in FANTOM II Trial

February 23, 2016

News Daily News

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Michael O'Riordan

February 23, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

Presentation

Bioresorbable Coronary Scaffold Thrombosis

Presenter: S. Puricel

February 22, 2016

News Daily News

覆膜支架在治疗罕见先天性主动脉病症患者方面前景良好：COAST II

L.A. McKeown

February 21, 2016

News Daily News

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

L.A. McKeown

February 21, 2016

News Daily News

COAST II: Los Stents Recubiertos son Prometedores en Pacientes con Patologías Aórticas Congénitas Raras

L.A. McKeown

February 21, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Industry News

Nipro Medical Corporation launches the Cronus™ HP 0.035' OTW PTA Balloon Catheter in the United States

February 18, 2016

News Daily News

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

L.A. McKeown

February 16, 2016

News Daily News

SORT OUT IV al cabo de 5 Años: Se Confirma una Mejor Seguridad a Largo Plazo para los Stents de 2ª Generación

L.A. McKeown

February 16, 2016

Advertisement

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

推迟任意类型的支架患者的非心脏手术至少一年：登记表分析

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

Análisis de Registro: Postponer Cirugías No Cardíacas al Menos 1 Año en Pacientes Con Cualquier Tipo de Stents

Cardiovascular Risk of Prior Stent Implantation Among Patients Undergoing Noncardiac Surgery

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

REVA Achieves Target Patient Enrollment in FANTOM II Trial

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Bioresorbable Coronary Scaffold Thrombosis

覆膜支架在治疗罕见先天性主动脉病症患者方面前景良好：COAST II

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

COAST II: Los Stents Recubiertos son Prometedores en Pacientes con Patologías Aórticas Congénitas Raras

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

Nipro Medical Corporation launches the Cronus™ HP 0.035' OTW PTA Balloon Catheter in the United States

SORT OUT IV at 5 Years: Better Long-term Safety Confirmed for Second Generation Stents

SORT OUT IV al cabo de 5 Años: Se Confirma una Mejor Seguridad a Largo Plazo para los Stents de 2ª Generación

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content